You are on page 1of 14

7/21/2022

A. whole blood


B. serum
C. plasma
PREPARED BY: LEXUS P. DELFIN, RMT D. red blood cells

A. graduated cylinder – “graduate”, with calibrated A. Dupont ACA


marking. Used when high degree of accuracy is
not essential. It is not calibrated as accurate as B. Kodak Echtachem
volumetric flask. C. Hitachi
B.erlenmeyer flask – has a flat bottom. For D. Abbott VP
titration procedures.
C. volumetric flask
D. automated pipette or dispenser and diluter

A. potassium – major intracellular cation A. Accuracy


B. chloride – major extracellular anion B. Sensitivity
C. sodium C. Reliability
D. Specificity – ability of an analytical method
D. carbonic acid – weak electrolyte,
to measure only the analyte of
specifically, weak acid electrolyte
concern/interest

1
7/21/2022

 A. estrogen A. chloride – argentometric titration using


 B. growth hormone silver nitrate
 C. parathyroid hormone B. inorganic phosphorous – measured
 D. thyroid hormone
coloremetrically based on “ insoluble
rhodamine B phosphomolybdate”
C. calcium
D. magnesium

A. VMA – vanilylmandelic acid – metabolic byproduct of


norepinephrine and epinephrine. Detects
neuroblastoma. A. continuous flow analyzers
B. PSA – prostate specific antigen detects presence of
prostate cancer B. discrete analyzers
C. Ca 125 – detects ovarian cancer
C. dry chemistry
D. CEA – carginoembryonic antigen and detects
presence of colon and rectal cancer, prostate cancer D. slide chemistry
(but not that specific), ovarian cancer, lung, thyroid, or
liver cancer.

A. sequential A. sequential


B. parallel B. parallel
C. batch C. batch
D. random
D. random

2
7/21/2022

A. sequential A. sequential


B. parallel B. parallel
C. batch C. batch
D. random D. random

A. The reaction vessel is the plastic  A. DuPont aca


B. Sample and specimen transport is accomplished with a  B. Olympus demand
peristaltic pump  C. Kodak Ektachem
C. Air bubbles separate aliquots of same sample and isolate  D. centrifugal analyzers
one specimen from the other
D. mixing is done with the use of a glass coil inserted into
the flow path.

A. Accuracy – extent to which the mean A. True positives


measurement is close to the real/true value B. True negatives
B. Calibration C. False positives
C. Reference D. False negatives – subjects who have negative test
B. Precision – refers to the results but have the disease
repeatability/reproducibility of the method
(SD/CV)

3
7/21/2022

A. True positives A. True positives


B. True negatives B. True negatives
C. False positives – subjects who have a positive test C. False positives
result but do not have the disease D. False negatives
D. False negatives

A. True positives A. Mn++  lipase, pyruvate carboxylase, superoxide


dismutase
B. True negatives B. Fe++  peroxidase, nitrate reductase, catalase,
C. False positives
nitrogenase
C. Zn++  carboxypeptidase A (if atomic number is 1),
D. False negatives carbonic anhydrase (if atomic number is 1), glutamate
dehydrogenase
D. Cl-
- Magnesium  enolase, pyruvate kinase,
pyrophosphatase

 A. Liver alcohol dehydrogenase can metabolize ethanol to  A. Arsenic – “arsenicosis” – carcinogen that is gray/silver/white in appearance.
glycol-aldehyde, glycolic acid and glyoxylic acid. (does not have any odor or taste)
 Ethanol can lead to malnutrition and can exert direct toxicological  Signs and symptoms: red/swollen skin, lesions, nausea, muscle cramps,
effects due to its interference with hepatic metabolism and most common: tingling of fingers and toes
immunological functions.  C. Carbon dioxide – physiologically important gas produced by the body as a
 B. It is not easily excreted end can bring dilution with its result of cellular metabolism. Main mode of action: asphyxiant
prolonged accumulation in the body.  B. Cyanide – low concentrations of cyanide is toxic. It can refer to any chemical
 C. A small fraction is excreted unchanged into the lungs which that contains carbon-nitrogen bond. It is found on food (almonds, spinatch),
can lead to organ damage. medications (celexa, tagamet/cimetidine – for heartburn, benign gastric ulcer,
 D. Liver alcohol dehydrogenase can metabolize alcohol into duodenal ulcer, reflux disease/GERD)
acetaldehyde and acetic acid.  D. Carbon monoxide

4
7/21/2022

A. phenytoin  anti-epileptic drug and used in


cardiac arrythmia A. digoxin
B. digitoxin  cardioactive drug B. quinidine
C. theophylline  bronchodilator C. lidocaine
D. acetaminophen  anti-inflammatory D. procainamide  cardioactive drug. Used to
decrease heart rate and blood pressure, half-
life: 3-4 hrs

A. digoxin  half-life of 1-2 days A. dilantin – phenytoin “anticonvulsant”


B. quinidine B. tegretol – carbamazepine “anticonvulsant”
C. lidocaine C. mysoline – primidone “anticonvulsant”
D. procainamide D. ventolin – salbutamol “bronchodilator”

Premidone, valproic acid, carbamazepine

A. Ethanol -- acetaldehyde A. Ethanol


B. Methanol – formic acid/ formate
B. Methanol
C. Isopropyl
D. Cyanide -- thiocyante C. Isopropyl

D. Cyanide
Formic acid- metabolized to toxic form

5
7/21/2022

A. Ethanol A. Ethanol


B. Methanol B. Methanol
C. Isopropyl C. Isopropyl
D. Cyanide
D. Cyanide

A. Ethanol A. Carbon Monoxide


B. Methanol B. Arsenic
C. Isopropyl C. Mercury
D. None of these
D. Iron
Should be cyanide

A. Carbon Monoxide A. Carbon Monoxide


B. Arsenic B. Arsenic
C. Mercury C. Mercury
D. None of these D. Iron

Should be organophosphates

6
7/21/2022

A. Carbon Monoxide


A. Carbon Monoxide
B. Arsenic
B. Arsenic
C. Mercury
C. Mercury
D. Iron
D. Iron

A. Lead
B. Organophosphates A. Lead
C. Ethanol glycol B. Organophosphates
D. Ethanol C. Ethanol glycol
D. Ethanol

A. Lead A. Lead


B. Organophosphates B. Organophosphates
C. Ethanol glycol
C. Ethanol glycol
D. Ethanol
D. None of these

7
7/21/2022

A. Lead
B. Organophosphates A. Digoxin
C. Ethanol glycol B. Phenytoin
D. Ethanol C. Theophylline
D. Tylenol

A. Digoxin
A. Digoxin – cardioactive drug
B. Phenytoin –anticonvulsant B. Phenytoin
C. Theophylline -- bronchodilator C. Theophylline
D. None of these D. None of these

A. Digoxin A. Digoxin


B. Phenytoin B. Phenytoin
C. Theophylline C. Theophylline
D. None of these D. Tylenol

8
7/21/2022

A. Lithium A. Lithium


B. Methotrexate B. Methotrexate
C. Aspirin C. Aspirin
D. Cyclosporin D. Cyclosporin

A. Lithium
A. Lithium
B. Methotrexate
B. Methotrexate
C. Aspirin
C. Aspirin
D. Cyclosporin
D. Cyclosporin

A. Lidocaine – anesthetic effect  cardiac A. Lidocaine


arryhtmias B. Dilantin
B. Dilantin C. Steroids
C. Steroids D. Thioridazine
D. Thioridazine

9
7/21/2022

A. Lidocaine A. Lidocaine


B. Dilantin B. Dilantin
C. Steroids C. Steroids
D. Thioridazine D. Thioridazine

A. phencyclidine
B. amphetamine --stimulant  A. analgesic
C. methaqualone  B. antitussive
D. Iysergic acid diethyamide  C. increase mental alertness
 D. anesthetic and stimulatory

 A. inflammation
 A. add more pounds
 B. loss of taste
 B. loss some weight
 C. no effect at all
 C. ulceration
 D. it is not mentioned in the literature  D. loss of sensation

10
7/21/2022

 A. iron A. bone


 B. lead B. blood
 C. mercury C. liver
 D. organophosphate
D. kidney

A. RA 1695 A. lysergine


B. RA 5169 B. amphetamine
C. RA 6915 C. phencyclidine
D. RA 9165 D. methaqualone

 Major components of automated analyzers


 patient identification
 sampling
 sample and reagent transport
 Dilution
 is a mechanization of chemical analysis to minimize manual manipulation;  mixing
 Incubation
 These analyzers process large volume of tests with great speed and precision.
 Reaction vessels
 Analysis of measurement
 Data analysis

Automation cannot correct for deficiencies inherent in


methodology

11
7/21/2022

A. BATCH
A. BATCH
B. PARALLEL
B. PARALLEL
C. RANDOM ACCESS
C. RANDOM ACCESS
D. SEQUENTIAL
D. SEQUENTIAL

 All 3 basic approaches use batch analysis

66. WHICH AMONG THE THREE APPROACHES


OFFER RANDOM –ACCESSOR STAT
CAPABILITIES?
A. Continuous flow
B. Centrifugal analysis
C. Discrete analysis

 Centrifugal analysis
 Continuous flow analyzers Advantages
 Uses the force generated by centrifugation to transfer and then contain liquids in separate cuvettes for measurement at
 use liquid reagents that flow through a  Resolves the major consideration of uniformity in the perimeter of spinning rotor
common reaction vessel or pathway. the performance of tests because each sample  Batch analysis is the major advantage because reactions in all cuvettes are read simultaneously
follows the same reaction path
 Sample and specimen transport is  Discrete analyzers
Disadvantages
accomplished with a peristaltic pump.  house samples and reagents in separate containers.
 Carryover problem
 Air bubbles at regular intervals separate  Solutions travel through the instrument in its own reaction vessel.
 Wasteful use of continuously flowing reagents  Discrete analyzers are the most versatile analyzers, replacing continuous flow and centrifugal analyzer
aliquots of same sample and isolate one
specimen from the other.  Sophisticated continuous flow analyzers use  Disadvantage
parallel single channels to run multiple tests on  Need to maintain uniformity of quality in each cuvette so that a particular sample’s quality is not affected by the particular space that it
 bubbles also serve as cleaning media occupies.
each sample
 transport their samples in many ways, such as:
 mixing is done with the use of a glass  chain-driven pulley system e.g. DuPont aca
coil inserted into the flow path. As
 motorized carousel e.g. Olympus demand
sample mixture passes through the coil,
 proboscis and slide e.g. Kodak Ektachem
it is inverted and mixed via gravity
 Dilution of sample and reagents is accomplished with syringe pipets and pumps ( maybe peristaltic or pneumatic in design). They aspirate
 The reaction vessel is the tubing. and deliver precise volumes of fluid

12
7/21/2022

Analyzer Operations

 are biologic substances synthesized and released by cancer cells or


substances produced by the host in response to cancerous tissue.

 Factors Associated with the Pathogenesis of tumor


 Chemical carcinogens
 Radiation
 Viruses
 Heredity

1. high sensitivity for disease


1. high analytical sensitivity and specificity 2. Levels should reflect tumor burden
3. Levels should remain relatively constant and not fluctuate in patients with unstable
2. Accuracy and precision disease
3. rapid turn-around time 4. Should be undetectable or low in patients in complete remission
* Should predict outcome in patients with stable disease
4. easy to measure at a low cost
A. 1, 2, 3, and 4
a. 1, 2, 3, and 4
b. 1, 2, and 3
B. 1, 2, and 3
c. 1 and 2 C. 1, 2, and 4
d. 1 only D. 2 and 4

1. screening for disease in asymptomatic population  Electrolytes are minerals in your blood and other body fluids that carry an electric
charge.
2. diagnosis of disease in symptomatic patients
3. therapeutic monitoring and selection  An electrolyte is a substance that conducts electricity when dissolved in water.
Electrolytes are essential for a number of functions in the body.
4. prognostic indicator
 Many automatic processes in the body rely on a small electric current to function, and
- aid in clinical staging electrolytes provide this charge.
- measurement of tumor burden  Electrolytes interact with each other and the cells in the tissues, nerves, and muscles.
- detection of recurrence of disease (relapse) A balance of different electrolytes is crucial for the body to function.
A. 1, 2, 3, and 4
B. 1, 2, and 3
C. 1 and 3
D. 2 only

13
7/21/2022

1. Volume & osmotic regulation


2. Myocardial rhythm & contractility
3. Regulation of ATPase ion pumps
4. Maintenance of acid-base balance
A. 1, 2, 3, and 4
B. 1, 2, and 4
C. 1, 3, and 4
D. 2 and 4 only

14

You might also like